Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference

July 12, 2024

https://www.globenewswire.com/news-release/2024/07/12/2912367/0/en/Clearmind-Medicine-to-Present-Groundbreaking-Research-at-Psychedelic-Medicine-Israel-2024-Conference.html

Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces its participation in the upcoming Psychedelic Medicine – Israel 2024 conference. This event will take place in Tel Aviv, Israel from July 28th to 30th, bringing together leading experts and researchers from around the world in the field of psychedelic medicine.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.